Millendo Therapeutics (Millendo Therapeutics) Deferred Policy Acquisition Costs

View and export this data going back to 2012. Start your Free Trial

What is Millendo Therapeutics Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.

Industry

Comparable Companies

Traded in Other Exchanges

N/A

Address

110 Miller Avenue, Suite 100, Ann Arbor, MI, USA, 48104

Website

https://www.millendo.com

Millendo Therapeutics Inc is a biopharmaceutical company.

Executives

Mary Lynne Hedley	director	C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Howe John P Md	director	C/O BB&T, P O BOX 1250, WINSTON SALEM NC 27102-1250
Carol Giltner Gallagher	director	C/O ATARA BIOTHERAPEUTICS, INC., 3260 BAYSHORE BOULEVARD, BRISBANE CA 94005
Habib J Dable	director	C/O ACCELERON PHARMA INC., 128 SIDNEY STREET, CAMBRIDGE MA 02139
Carole Nuechterlein	director	C/O AVEXIS, INC., 2275 HALF DAY ROAD, SUITE 160, BANNOCKBURN IL 60015
Geoffrey Nichol	director	MEDAREX, 707 STATE ROAD, PRINCETON NJ 08540
James M. Hindman	director	2525 DUPONT DRIVE, IRVINE CA 92612
Christophe Arbet-engels	officer: Chief Medical Officer	C/O MILLENDO THERAPEUTICS, INC., 110 MILLER AVENUE, SUITE 100, ANN ARBOR MI 48104
Ryan Zeidan	officer: Chief Development Officer	C/O MILLENDO THERAPEUTICS, INC., 110 MILLER AVENUE, SUITE 100, ANN ARBOR MI 48104
Julia C. Owens	director, officer: President and CEO	C/O OVASCIENCE, INC., 9 FOURTH AVENUE, WALTHAM MA 02451
Tamara L Joseph	officer: General Counsel and Secretary	32 GARRISON STREET, APT 50-103, BOSTON MA 02116
Arcudi Iii Louis J	officer: Chief Financial Officer	C/O IDERA PHARMACEUTICALS 167 SYDNEY ST, CAMBRIDGE MA 02139
Randall W Whitcomb	director	10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807
Jeffery M. Brinza	officer: Sec., CAO and General Counsel	C/O OVASCIENCE, INC., 9 FOURTH AVENUE, WALTHAM MA 02451
Pharis Mohideen	officer: Chief Medical Officer	C/O OVASCIENCE, INC., 9 FOURTH AVENUE, WALTHAM MA 02451